See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Artificial Intelligence
Soccer
Social Media
Inflation
Baseball
Sanctions
European Union
Vladimir Putin
NHS
Mother's Day
Infrastructure
Published • loading... • Updated

ARVO 2025: Carl Danzig, MD, recaps the first stage of a phase 3 study of drop-based DME therapy

Summary by modernretina.com
According to Dr. Danzig, the DIAMOND trial demonstrates efficacy of OCS-01, a topical drop, in patients with diabetic macular edema.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
modernretina.commodernretina.com

ARVO 2025: Carl Danzig, MD, recaps the first stage of a phase 3 study of drop-based DME therapy

According to Dr. Danzig, the DIAMOND trial demonstrates efficacy of OCS-01, a topical drop, in patients with diabetic macular edema.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

modernretina.com broke the news in on Wednesday, May 7, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Maryland

Maryland

News
For You
SearchBlindspotLocal